"A surgeon is surrounded by people who are sick, discouraged, afraid, embittered, dying - but also courageous, loving, wise, compassionate and alive" Bernie Siegel
“Love is like the human appendix. You take it for granted while it's there, but when it's suddenly gone you're forced to endure horrible pain that can only be alleviated through drugs.”
― Reverend Jen,
Choledochal cysts should be considered in the differential diagnosis in all patients with a history of biliary colic, recurrent cholangitis or pancreatitis with associated dilatation of bile duct, particularly if they are <40 years of age. Delay in the diagnosis increases the incidence of associated biliary pathology and suboptimal surgical therapy
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
3. Osmolality
The solute concentration in the body fluid by weight. The number of
miliosmoles (mOsm) in a kilogram (kg) of a solution.
Normal Plasma Osmolality = 275-295 mOsm/kg
6. Patient Identification
Acute presentations with vomiting or diarrhea, including intestinal
obstruction, biliary colic, gastroenteritis.
Patients who had been immobile or debilitated for a period before
presentation causing reduced fluid intake, like, pancreatitis, pneumonia,
prolonged sepsis, acute on chronic vascular insufficiency.
Drugs that impair renal response to fluid changes, like diuretics.
Patients with low body weight and with overall lower total body fluid
volume in whom similar losses have a greater effect.
7. Daily Losses
Water loss 2500ml/day (insensible losses from skin, respiratory and GI
tract, and in urine). ↑ loss in sepsis, ventilation, diarrhea, vomiting, high
output fistulas, polyuric renal failure
Na+ 100mmol/day in urine. ↑ loss in pyrexias, diarrhea, vomiting, high
output fistulas.
K+ 80mmol/day in urine. ↑ loss in pyrexias, diarrhea, vomiting, high
output fistulas.
8. Maintenance Fluid Calculation (Rules)
4/2/1 Rule
4ml/kg for first 10 kg
2ml/kg for next 10kg
1ml/kg for every next kg
Example for a 80kg patient,
10kg x 4ml/kg = 40ml
10kg x 2ml/kg = 20ml
60kg x 1ml/kg = 60ml
Maintenance rate = 120ml/hour and total fluid per day required is 2880ml
9. +40 Rule
If the patient weighs more than 40kg, add 40 to the weight and that will be
maintenance amount of fluid per hour.
Example for a 80kg patient
Adding 40 in the weight
Total maintenance fluid for this patient will be 120ml/hour.
Hence total fluid required in a day will be 2880ml by using this rule.
Electrolytes
Sodium (Na+): 1-2 mmol/kg/day
Potassium (K+): 0.5-1 mmol/kg/day
10. Calculation of IV Flow Rates
Intravenous fluids must be given at a specific rate, neither too fast nor too
slow.
The specific rate may be measured as ml/hr, litre/hr or drops/min.
To control or adjust the flow rate only drops/min are used.
Drop Factor
Drop factor is the number of drops in one milliter used in IV fluid
administration, also called drip factor.
A number of different drop factors are used but the commonest are:
Blood Set (10 drops/ml)
Regular Set (15 drops/ml)
Burette or Peadiatric Chamber (60 drops/ml)
11. Calculation of IV Flow Rates
Formula:
volume(ml) x drop factor / time(min)
Example
1500ml IV fluids are to be given over 12 hours. Using a drop factor of
15 drops/min.
1500 × 15
12 × 60
= 31 drops/minute
12. Management
The goal of fluid therapy is to maintain the urine output of
0.5 – 1.0 ml/kg/day
Avoidance of fluid overload, especially in malnutrition, heart failure, and
renal insufficiency patients.
GI losses that exceed 250ml/day should be replaced with equal volume of
crystalloids.
The minimum urine volume required to maintain normal BUN and
Creatinine is 0.24ml/kg/hr (oliguria is less than 400ml/day)
BUN to Cr ratio is helpful in assesment of hydration status,
If BUN/Cr more than 20, dry side
If BUN/Cr less than 10, wet side
13. Assessment of Volume Status
History and Examination
The dry patient. May have been NPO several days preoperatively, feels thirsty,
complains of dry mouth, dehydration could be due to diarrhea or vomiting, low
JVP, dry mucous membranes and reduced skin turgor
The over-filled patient. No thirsty feeling, raised JVP, normal skin turgor, may
have dependent edema, and evidence of pulmonary edema on auscultation
Observations Chart
The dry patient. May have falling BP, rising pulse, low CVP not rising with fluid
challenges, weight several kilos below preoperative weight.
The over-filled patient. Not usually tachycardic and has high CVP that rises
and plateaues with fluid challenges, BP falling with fluid challenges and weight
several kilos above the preoperative weight.
14. Assessment of Volume Status
Fluid balance chart
The dry patient. Usually be in several liters of negative fluid balance, possibly
over a few days, with a urine output less than 1ml/kg/hr.
The over-filled patient. Will be in several liters of positive fluid balance,
possibly over a few days. Urine output may be low because of heart failure or
renal dysfunction.
Blood results
The dry patient. ↑ sodium, potassium, creatinine, and urea
The over-filled patient. May have hyponatremia.
CXR
The dry patient. No evidence of pulmonary edema or effusions.
The over-filled patient. May have both pulmonary edema and effusions.
15. Sodium (Na+)
Normal values: 135 - 145 mEq/l
Calculation of Sodium defeict in mEq
Total body water x (Desired Na - Serum Na)
TBW (Adult Male) = 0.6 x weight (kg)
TBW (Adult Female) = 0.5 x weight (kg)
20. Management of Hyponatremia
Asymptomatic: increase the sodium level by no more than 0.5-1meq/L/h
to a maximum increase of 10meq/L per day
Symptomatic: (Na<120meq/L) Increase the sodium level by no more than
1meq/L per hour until the serum Na level reaches 130meq/L or neurologic
symptoms are improved
25. Management
Potassium removal
Kayexalate
Oral administration is 15-30g in 50-100 ml of 20% sorbitol
Rectal administration is 50g in 200 ml 20% sorbitol
Dialysis
Shift potassium
Glucose 1 vial of D50% and regular insulin 5-10 units intravenous
Bicarbonate 1 vial intravenous
Counteract cardiac effects
Calcium gluconate 5-10 mL of 10% solution
26.
27. Hypokalemia
Inadequate intake
Dietary, potassium-free intravenous fluids, potassium-deficient
total parenteral nutrition
Excessive potassium excretion
Hyperaldosteronism
Medications
Gastrointestinal losses
Direct loss of potassium from gastrointestinal fluid (diarrhea)
Renal loss of potassium (gastric fluid, either as vomiting or high nasogastric
output)
Intracellular-shift (metabolic alkalosis or insulin therapy)
29. Management
Serum potassium level <4.0 mEq/L
Asymptomatic, tolerating enteral nutrition:
KCl 40 to 100 mEq/day via entral access
Asymptomatic, not tolerating entral nutrition
Intravenous KCl at rate of 10 to 20 mEq/hour
If infused at rate >10meq then cardiac monitoring required.
Rate can be 40meq through Central lines.
Increased losses from lungs in dry atmospheres or in patients with tracheostomy, hence humidification of air is important.
This 1500ml/day urine output is warranted for normal functioning kidneys. A minimum of 400ml/day output is required to excrete the end products of protein metabolism.
D5W is considered a isotonic solution but once the dextrose is metabolized it acts as a hypotonic solution causing the fluid shifts into the cells.
LR is technically the closest fluid to serum composition.
NS is most widely used fluid. With adequate renal function NS prevents rapid cellular fluid shifts during rehydration and excess Na is excreted via kidneys. K should usually to be added only if low serum K is present.